Znanstveni rad - Izvorni znanstveni rad
Canonical Wnt/β-catenin signaling pathway is dysregulated in patients with primary and secondary myelofibrosis
Clinical Lymphoma Myeloma and Leukemia, 16 (2016), 9; 523-256. https://doi.org/10.1016/j.clml.2016.06.004

Lucijanić, Marko; Livun, Ana; Tomasović-Lončarić, Čedna; Štoos-Veić, Tajana; Pejša, Vlatko; Jakšić, Ozren; Prka, Željko; Kušec, Rajko

Citirajte ovaj rad

Lucijanić, M., Livun, A., Tomasović Lončarić, Č., Štoos Veić, T., Pejša, V., Jakšić, O. ... Kušec, R. (2016). Canonical Wnt/β-catenin signaling pathway is dysregulated in patients with primary and secondary myelofibrosis. Clinical Lymphoma Myeloma and Leukemia, 16. (9), 523-256. doi: 10.1016/j.clml.2016.06.004

Lucijanić, Marko, et al. "Canonical Wnt/β-catenin signaling pathway is dysregulated in patients with primary and secondary myelofibrosis." Clinical Lymphoma Myeloma and Leukemia, vol. 16, br. 9, 2016, str. 523-256. https://doi.org/10.1016/j.clml.2016.06.004

Lucijanić, Marko, Ana Livun, Čedna Tomasović Lončarić, Tajana Štoos Veić, Vlatko Pejša, Ozren Jakšić, Željko Prka i Rajko Kušec. "Canonical Wnt/β-catenin signaling pathway is dysregulated in patients with primary and secondary myelofibrosis." Clinical Lymphoma Myeloma and Leukemia 16, br. 9 (2016): 523-256. https://doi.org/10.1016/j.clml.2016.06.004

Lucijanić, M., et al. (2016) 'Canonical Wnt/β-catenin signaling pathway is dysregulated in patients with primary and secondary myelofibrosis', Clinical Lymphoma Myeloma and Leukemia, 16(9), str. 523-256. doi: 10.1016/j.clml.2016.06.004

Lucijanić M, Livun A, Tomasović Lončarić Č, Štoos Veić T, Pejša V, Jakšić O, i sur.. Canonical Wnt/β-catenin signaling pathway is dysregulated in patients with primary and secondary myelofibrosis. Clinical Lymphoma Myeloma and Leukemia [Internet]. 09.2016. [pristupljeno 25.07.2024.];16(9):523-256. doi: 10.1016/j.clml.2016.06.004

M. Lucijanić, et al., "Canonical Wnt/β-catenin signaling pathway is dysregulated in patients with primary and secondary myelofibrosis", Clinical Lymphoma Myeloma and Leukemia, vol. 16, br. 9, str. 523-256, Rujan 2016. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:690434. [Citirano: 25.07.2024.]

Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.